$LAGBF
Isodiol enters licensing deal with Canopy Growth
Isodiol International's June sales at $1.84-million
2017-07-11 10:18 ET - News Release
Mr. Marcos Agramont reports
Isodiol International Inc. has released its unaudited consolidated sales figures of $1,843,173 for the 30-day period ended June 30, 2017. The company recorded sales of $1,843,173 for the 30-day period ended June 30, 2017. Total quarterly sales were $4,919,693 for the period April 1 to June 30, 2017.
2017-07-20 02:09 ET - News Release
Also News Release (C-WEED) Canopy Growth Corp
Mr. Marcos Agramont of Isodiol reports
ISODIOL INTERNATIONAL INC. SIGNS DEFINITIVE LICENSING AGREEMENT WITH CANOPY GROWTH CORPORATION FOR CANADIAN AND INTERNATIONAL DISTRIBUTION
Isodiol International Inc. has signed a licensing agreement with Canopy Growth Corp.
Canopy Growth is the world's premier cannabis company that operates a collection of diverse brands and curated strain varieties, supported by over half a million square feet of indoor and greenhouse production capacity. Under this licensing agreement, Canopy Growth will have the right to manufacture and distribute the company's Pot-O-Coffee and Pot-O-Tea branded marijuana-infused single-serve K-Cup products in Canada and certain other markets internationally as federal regulations allow. Licensed products include caffeinated and decaffinated product lines, as well as Isodiol's single-serve Pot-O-Coco. In addition to the Canadian rights, Canopy Growth shall have the right of first refusal to sell the Pot-O brand products in any territory outside of the United States, Mexico and Puerto Rico.
"This distribution agreement has us positioned to increase our global footprint with the largest cannabis company in the world," said Marcos Agramont, chief executive officer, Isodiol.
"We will continue to develop our Pot-O-Coffee product lines with ready-to-drink and cold-brew products while working with Canopy Growth for international distribution channels. The Pot-O-Coffee brand is well recognized, and adding additional products to this line will continue to strengthen its market presence," stated Isodiol's Mr. Agramont.
The availability of the various licensed products in Canada and elsewhere will differ depending on applicable laws and regulation. While Canadian law does not yet permit the manufacture and sale of marijuana-infused products, the company anticipates that such products will be permitted in the near future. Furthermore, currently proposed regulations, which would permit the sale of infused products, would not allow such products to contain both marijuana and caffeine. As such, the specific product offerings in Canada and elsewhere may be limited. The company will provide additional updates as regulations are adopted and as product rollout plans are developed.
About Isodiol International Inc.
Isodiol International is the market leader in pharmaceutical-grade cannabis compounds and the industry leader in the manufacturing and development of consumer products. Isodiol's nutraceutical division is the pioneer of many firsts for hemp-derived cannabidiol (CBD), including 99 per cent pure crystalline isolate, microencapsulation, and nanotechnology for the highest-quality consumable and topical skin care products.
Isodiol's growth strategy includes the development of over-the-counter and pharmaceutical drugs, seeking joint ventures and acquisitions to expand its portfolio of brands and subsidiaries, and will aggressively continue international expansion into Latin America, Asia and Europe.
We seek Safe Harbor.
News 
Market Data 
Discover 
